iShares Global Healthcare ETF (NYSEARCA:IXJ) Sees Unusually-High Trading Volume – Still a Buy?

Shares of iShares Global Healthcare ETF (NYSEARCA:IXJ) saw unusually-high trading volume on Monday . 756,683 shares traded hands during trading, an increase of 177% from the previous session’s volume of 272,696 shares.The stock last traded at $106.58 and had previously closed at $106.85.

iShares Global Healthcare ETF Price Performance

The stock has a market cap of $4.35 billion, a PE ratio of 21.58 and a beta of 0.56. The firm’s 50 day moving average price is $99.81 and its two-hundred day moving average price is $96.94.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Franklin Resources Inc. lifted its position in shares of iShares Global Healthcare ETF by 80.0% during the second quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock worth $31,000 after acquiring an additional 160 shares in the last quarter. Arax Advisory Partners purchased a new position in shares of iShares Global Healthcare ETF in the fourth quarter valued at $31,000. Farther Finance Advisors LLC raised its stake in shares of iShares Global Healthcare ETF by 35.6% during the 4th quarter. Farther Finance Advisors LLC now owns 484 shares of the company’s stock valued at $47,000 after purchasing an additional 127 shares during the period. RMG Wealth Management LLC bought a new stake in shares of iShares Global Healthcare ETF during the 1st quarter valued at $47,000. Finally, Triumph Capital Management bought a new stake in shares of iShares Global Healthcare ETF during the 3rd quarter valued at $53,000.

About iShares Global Healthcare ETF

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.